Note: Ingredients listed on restricted chemical lists
EC/CAS
110-54-3
Name of the chemical
n-Hexan (790/2009)
Concentration
0.6%
EC/CAS
7727-37-9
Name of the chemical
Nitrogen N2
Concentration
78.5-
General Information
Revision date
2018-01-06
Product name
Hexane 0.0001% to 0.6%, in Air
Product Synonyms
Hexane in Air; n-Hexane in Air
Chemical name
Gas Mixture
1.2.1 Relevant identified uses
Calibration of analyitical instrumentation
supplier name
NorLab a division of Norco
Icons in SDS
Company Information
company name
NorLab a division of Norco
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Classification of Substance
Signal word
WARNING
Hazard statements
H280 - Contains gas under pressure; may explode if heated CGA-HG24 - SUPPORTS COMBUSTION.
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood. P261 - Avoid breathing dust/fume/gas/mist/vapors/spray. P281 - Use personal protective equipment as required. P304+340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P271 - Use only outdoors or in a well-ventilated area. P410+412 - Protect from sunlight. Do not expose to temperatures exceeding 50 °C/122 °F CGA-PG05 - Use a back flow preventive device in the piping. CGA-PG06 - Close valve after each use and when empty. CGA-PG10 - Use only with equipment rated for cylinder pressure.
Principle Routes of Exposure
Target Organs Eyes; Inhalation; Skin; Repeated exposure to Hexane may damage the nervous system causing peripheral neuropathy often characterized by weakness and numbness in the arms and legs. Symptoms generally disappear within a few months after exposure stops. Any type of paresthesia may be aggravated by hexane exposure. Inhalation Gas mixture contains sufficient oxygen to support life (at least 99.4% of mix is air). Inhalation of high concentrations of hexane vapors may depress the central nervous system causing dizziness, difficulty in walking, respiratory tract irritation, numbness of the extremities and may result in eventual respiratory paralysis at very high concentrations. Symptoms may include headaches, weakness in the fingers and toes, blurred vision, appetite and weight loss, nausea, and throat irritation. Skin Contact Contact with rapidly expanding gas near the point of release may cause frostbite with redness, skin color change to gray or white, and blistering. Eye Contact None anticipated. Contact with rapidly expanding gas near the point of release may cause frostbite. Ingestion Not anticipated. Product is a gas at normal conditions.
2.1 Classification of the substance or mixture
GHS Classification in Accordance with 29 CFR 1910 (OSHA HCS)